OIL optiscan imaging limited

phase three trials

  1. 3,025 Posts.
    lightbulb Created with Sketch. 220
    This is good news. Looks like two trials from the Barrow institute to assess 5-ALA fluorescence agent with confocal microscope in brain surgery. This would be the phase 3 confirmatory trial. The primary completion date may have already passed

    Column 1 Column 2
    0 Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=1

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=721822&version=Patient

    https://www.clinicaltrials.gov/ct2/...urgery for Low- and High-grade Gliomas&rank=2


    https://www.clinicaltrials.gov/ct2/...or Low- and High-grade Gliomas &Search=Search

    Whatever the traders are doing atm won`t matter with positive outcomes from these trials.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.5¢
Change
0.001(1.19%)
Mkt cap ! $71.00M
Open High Low Value Volume
8.3¢ 8.5¢ 8.1¢ $10.90K 132.6K

Buyers (Bids)

No. Vol. Price($)
4 125000 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 60000 1
View Market Depth
Last trade - 15.36pm 19/09/2025 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.